Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nanogene editing drug delivery systems in the treatment of liver fibrosis

25 Sept 2024

Abstract excerpt

Liver fibrosis is a group of diseases that seriously affect the health of the world's population. Despite significant progress in understanding the mechanisms of liver fibrogenesis, the technologies and drugs used to treat liver fibrosis have limited efficacy. As a revolutionary genetic tool, gene editing technology brings new hope for treating liver fibrosis. Combining nano-delivery systems with gene editing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Viral gastroenteritis research and epidemiology
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39386741
DOI: 10.3389/fmed.2024.1418786

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nanogene editing drug delivery systems in the treatment of liver fibrosisPMID 39386741Read ↗

Advances in precision gene editing for liver fibrosis: From technology to therapeutic applicationsSemantic proximity Read ↗

Insights on drug and gene delivery systems in liver fibrosisSemantic proximity Read ↗

Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular CarcinomaSemantic proximity Read ↗

Gene therapy for liver diseases — progress and challengesSemantic proximity Read ↗

RNA nanomedicine in liver diseasesSemantic proximity Read ↗

In vivo liver targeted genome editing as therapeutic approach: progresses and challengesSemantic proximity Read ↗

Emerging mRNA Technology for Liver Disease TherapySemantic proximity Read ↗

Novel vectors and approaches for gene therapy in liver diseasesSemantic proximity Read ↗

Gene therapy: advances, challenges and perspectivesSemantic proximity Read ↗

Viral delivery of compact CRISPR-Cas12f for <i>in vivo</i> gene editing applicationsSemantic proximity Read ↗

The Future of Gene Therapy: A Review of In Vivo and Ex Vivo Delivery Methods for Genome Editing-Based TherapiesSemantic proximity Read ↗

CRISPR/Cas9 therapeutics for liver diseases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.